Patient Advocate Foundation, Our Newest Partner!
Our newest Metastatic Trial Search partner is Patient Advocate Foundation (PAF). PAF helps guide patients and their families through complex healthcare challenges...
Read MoreWhy Attend a Medical Conference?
Patients attend medical conferences to network with other patients, learn about cutting-edge research, and participate in ways that allow the patient voice to be...
Read MoreAll About Phase IV Clinical Trials
In the last 3 months, we highlighted what to know about phase I, phase II, and phase III clinical trials. In the last of our four-part series, we are discussing...
Read MoreUpdate on Immunotherapy for MBC: Immune Checkpoint Inhibitors
Immune checkpoint inhibitors are a type of immunotherapy that uses the immune system’s natural ability to fight cancer. Immunotherapy is an active area of...
Read MoreWhy Do Some People Have an Exceptional Response When Being Treated for MBC?
Exceptional responders, also called atypical responders, are people with cancer who have responded to treatments that are not as effective for other people. Many...
Read MoreAll About Phase III Clinical Trials
In the last 2 months, we highlighted what to know about phase I and phase II clinical trials. In the third of our four-part series, we are discussing phase III...
Read MoreWhat is Complementary and Integrative Medicine?
Practices such as yoga, acupuncture, massage, and others can ease cancer symptoms and decrease treatment side effects. When these practices are used in addition...
Read MoreUpdate On Antibody-Drug Conjugates (ADCs) For MBC
Antibody-drug conjugates consist of an antibody attached to a chemotherapy drug that delivers chemotherapy only where it is needed, limiting unwanted side...
Read MoreAll About Phase II Clinical Trials
Last month, we highlighted what to know about phase I clinical trials. In the second of our four-part series, we are discussing phase II clinical trials. Phase II...
Read MoreSEARCH OUR SITE
for past articles or specific information.